Trial for multiple sclerosis drug focused on Hispanic and Black patients
|
About
30% of people with MS in the United States are Black and Latino Americans,
but they're rarely in clinical trials. |
Foster innovation or mitigate risk? AI regulation in Latin America
Artificial intelligence is probably the most popular discussion topic of our times. And it is certainly something that governments around the ... View article...